US Stock MarketDetailed Quotes
XENE Xenon Pharmaceuticals
- 41.110
- -0.780-1.86%
Close Oct 31 16:00 ET
- 41.110
- 0.0000.00%
Post 17:00 ET
3.11BMarket Cap-15058P/E (TTM)
42.340High40.790Low332.68KVolume41.640Open41.890Pre Close13.80MTurnover0.48%Turnover RatioLossP/E (Static)75.76MShares50.99052wk High3.69P/B2.88BFloat Cap27.98552wk Low--Dividend TTM69.99MShs Float50.990Historical High--Div YieldTTM3.70%Amplitude2.100Historical Low41.493Avg Price1Lot Size
Xenon Pharmaceuticals Key Stats
EPS
According to the latest financial report of Xenon Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.75. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Xenon Pharmaceuticals's free cash flow? The latest report shows it as -34.19M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Xenon Pharmaceuticals shows that the company's current ratio is 23.27, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Xenon Pharmaceuticals, the quick ratio is 23.09, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Xenon Pharmaceuticals? The latest ROE figure is -6.69%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Xenon Pharmaceuticals, the total asset return on investment (ROA) is -6.43%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Xenon Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Xenon Pharmaceuticals, the net profit margin is -28.14K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data